We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+74.55%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$611M
AUM Growth
+$189M
Cap. Flow
+$13.6M
Cap. Flow %
2.23%
Top 10 Hldgs %
10.32%
Holding
440
New
177
Increased
32
Reduced
81
Closed
148

Top Buys

Rank Stock Value
1
CALY
Callaway Golf Company
CALY
+$6.91M
2
GNTX icon
Gentex
GNTX
+$6.43M
3
APAM icon
Artisan Partners
APAM
+$5.25M
4
SSTK icon
Shutterstock
SSTK
+$5.01M
5
VCEL icon
Vericel Corp
VCEL
+$3.84M

Top Sells

Rank Stock Value
1
CRDF icon
Cardiff Oncology
CRDF
+$5.05M
2
WKHS icon
Workhorse Group
WKHS
+$4.62M
3
CYRX icon
CryoPort
CYRX
+$4.55M
4
SITM icon
SiTime
SITM
+$3.83M
5
MCRB icon
Seres Therapeutics
MCRB
+$3.78M

Sector Composition

Rank Sector Weight
1 Healthcare 26%
2 Technology 24.89%
3 Consumer Discretionary 15.91%
4 Industrials 14.11%
5 Financials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
76
Natera
NTRA
$38B
$2.29M 0.38%
23,027
-6,227
-21% -$520K
LMND icon
77
Lemonade
LMND
$4.01B
$2.29M 0.37%
+18,665
New +$1.38M
TTEK icon
78
Tetra Tech
TTEK
$8.89B
$2.28M 0.37%
+98,550
New +$2.22M
FPRX
79
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.28M 0.37%
+134,162
New +$1.68M
ACH
80
Accendra Health
ACH
$224M
$2.28M 0.37%
84,156
-36,065
-30% -$928K
MXL icon
81
MaxLinear
MXL
$6.37B
$2.26M 0.37%
+59,078
New +$1.71M
ARVN icon
82
Arvinas
ARVN
$568M
$2.25M 0.37%
+26,534
New +$915K
AEIS icon
83
Advanced Energy
AEIS
$13B
$2.24M 0.37%
+23,108
New +$1.97M
COOP
84
DELISTED
Mr. Cooper
COOP
$2.24M 0.37%
72,109
+6,884
+11% +$176K
TPIC
85
DELISTED
TPI Composites
TPIC
$2.23M 0.37%
42,327
+565
+1% +$22.6K
WOLF icon
86
Wolfspeed
WOLF
$1.43B
$2.23M 0.36%
+21,036
New +$1.69M
AVID
87
DELISTED
Avid Technology Inc
AVID
$2.23M 0.36%
+140,247
New +$1.57M
BPMC
88
DELISTED
Blueprint Medicines
BPMC
$2.22M 0.36%
19,813
-703
-3% -$74.1K
TWST icon
89
Twist Bioscience
TWST
$6.84B
$2.21M 0.36%
15,678
-6,312
-29% -$700K
DECK icon
90
Deckers Outdoor
DECK
$13.3B
$2.21M 0.36%
46,302
+4,344
+10% +$193K
CDLX icon
91
Cardlytics
CDLX
$20.7M
$2.21M 0.36%
+1,548
New +$1.65M
DNLI icon
92
Denali Therapeutics
DNLI
$3.92B
$2.2M 0.36%
26,214
-14,973
-36% -$905K
CDNA icon
93
CareDx
CDNA
$2.32B
$2.19M 0.36%
+30,186
New +$1.75M
EDIT icon
94
Editas Medicine
EDIT
$445M
$2.17M 0.35%
+30,895
New +$1.27M
MYRG icon
95
MYR Group
MYRG
$5.16B
$2.16M 0.35%
+35,992
New +$1.79M
AGYS icon
96
Agilysys
AGYS
$3.03B
$2.16M 0.35%
+56,313
New +$1.87M
SGRY icon
97
Surgery Partners
SGRY
$1.95B
$2.16M 0.35%
74,468
+995
+1% +$24.8K
UPWK icon
98
Upwork
UPWK
$1.16B
$2.16M 0.35%
+62,461
New +$1.79M
INSP icon
99
Inspire Medical Systems
INSP
$1.7B
$2.15M 0.35%
11,443
-12,479
-52% -$2.04M
BE icon
100
Bloom Energy
BE
$67.4B
$2.13M 0.35%
74,149
+13,580
+22% +$290K

Similar funds

EAM Investors's Q4 2020 Portfolio in Review

As of Q4 2020, EAM Investors held 440 positions worth $611M, up 45% from $422M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors's Q4 2020 filing shows 177 new, 32 increased, 81 reduced and 148 closed positions. Its largest new stake was Callaway Golf Company: 338,637 shares worth $8.13M. The largest sale was Cardiff Oncology, an estimated $5.05M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

  • EAM Investors's largest Q4 2020 buy was Callaway Golf Company: 338,637 shares worth $8.13M.
  • EAM Investors added most to Artisan Partners in Q4 2020, an estimated $5.25M increase.
  • EAM Investors's biggest Q4 2020 reduction was Cardiff Oncology, cutting an estimated $5.05M.
  • EAM Investors fully exited Workhorse Group in Q4 2020, selling an estimated $4.62M.
  • EAM Investors's ten largest holdings make up 10% of its $611M portfolio in Q4 2020.
  • EAM Investors opened 177 new positions and closed 148 in Q4 2020.
  • EAM Investors's portfolio value rose 45% quarter-over-quarter to $611M.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.